Skip to Content

MeVis Medical Solutions AG M3V

Morningstar Rating
€26.20 −0.20 (0.76%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

M3V is trading at a 131% premium.
Price
€26.34
Fair Value
€65.24
Uncertainty
Very High
1-Star Price
€28.16
5-Star Price
€11.26
Economic Moat
Mwtwgh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if M3V is a good fit for your portfolio.

Trading Information

Previous Close Price
€26.40
Day Range
€26.2026.20
52-Week Range
Bid/Ask
€0.00 / €0.00
Market Cap
€47.68 Mil
Volume/Avg
0 / 207

Key Statistics

Price/Earnings (Normalized)
8.54
Price/Sales
2.77
Dividend Yield (Trailing)
3.60%
Dividend Yield (Forward)
3.60%
Total Yield
3.63%

Company Profile

MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Core
Total Number of Employees
117

Comparables

Valuation

Metric
M3V
SYAB
300030
Price/Earnings (Normalized)
8.5481.03
Price/Book Value
2.700.992.08
Price/Sales
2.770.882.40
Price/Cash Flow
10.568.2613.20
Price/Earnings
M3V
SYAB
300030

Financial Strength

Metric
M3V
SYAB
300030
Quick Ratio
1.611.030.80
Current Ratio
1.661.161.12
Interest Coverage
115.962.17−3.32
Quick Ratio
M3V
SYAB
300030

Profitability

Metric
M3V
SYAB
300030
Return on Assets (Normalized)
17.65%0.86%−3.84%
Return on Equity (Normalized)
27.60%1.87%−7.45%
Return on Invested Capital (Normalized)
27.23%2.44%−3.91%
Return on Assets
M3V
SYAB
300030
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common StockTvfby$38.1 Bil
VEEV
Veeva Systems Inc Class ABtnsmzfjzYkj$32.9 Bil
SOLV
Solventum CorpZyfsv$11.2 Bil
PMCUF
Pro Medicus LtdZbtbsyr$8.0 Bil
MTHRF
M3 IncVtnym$7.4 Bil
MTHRY
M3 Inc ADRRhhgqb$7.4 Bil
HQY
HealthEquity IncMzpygm$6.7 Bil
RCM
R1 RCM IncFzrw$5.1 Bil
DOCS
Doximity Inc Class ARdfsxy$4.4 Bil
TXG
10x Genomics Inc Ordinary Shares - Class AMwdw$3.2 Bil

Sponsor Center